47.73.Z - Retail sale of pharmaceutical products
41.10.Z - Construction work related to the construction of residential and non-residential buildings
47.74.Z - Retail sale of medical and orthopedic products
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
68.20.Z - Rental and management of own or leased real estate
73.20.Z - Market research and public opinion polling
78.30.Z - Employment activities
82.99.Z - Other business support activities, not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 1,2 | 1,6 | 1,7 | 4,4 |
Gross profit (loss) | 1,2 | 1,6 | 1,6 | 1,2 |
EBITDA | 1,3 | 1,7 | 1,7 | 0,7 |
Short time liabilities | 0,9 | 1,4 | 1,3 | -12,4 |
Other operating costs | 0 | 0 | 0,1 | 402,1 |
Equity capital | 2,2 | 1,7 | 2,7 | 61,4 |
Operating profit (EBIT) | 1,2 | 1,6 | 1,6 | 2 |
Assets | 3,2 | 3,1 | 4 | 27,3 |
Net profit (loss) | 1,2 | 1,6 | 1,6 | 1,2 |
Cash | 0,5 | 0,5 | 1,2 | 128,4 |
Net income from sale | 20,9 | 23,2 | 24,1 | 3,6 |
Liabilities and provisions for liabilities | 1 | 1,4 | 1,3 | -11,8 |
Working assets | 2,8 | 2,8 | 3,8 | 35,7 |
Other income costs | 0 | 0 | 0 | 1160,9 |
Depreciation | 0,1 | 0,1 | 0,1 | -23,4 |
% | % | % | p.p. | |
Profitability of capital | 52,5 | 97 | 60,8 | -36,2 |
Equity capital to total assets | 69,8 | 53,4 | 67,7 | 14,3 |
Gross profit margin | 5,6 | 6,9 | 6,8 | -0,1 |
EBITDA Margin | 6 | 7,3 | 7,1 | -0,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 17 | 22 | 19 | -3 |
Current financial liquidity indicator | 3.010488271713257 | 1.9366008043289185 | 3.0010080337524414 | 1,1 |
Net dept to EBITDA | -0.42066287994384766 | -0.31288108229637146 | -0.7093363404273987 | -0,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane